Mushtaq B - Search Results

1

Adalimumab for sight-threatening uveitis in Behçet's disease.

Mushtaq B, Saeed T, Situnayake RD, Murray PI. Mushtaq B, et al. Eye (Lond). 2007 Jun;21(6):824-5. doi: 10.1038/sj.eye.6702352. Epub 2006 Apr 7. Eye (Lond). 2007. PMID: 16601736

2

Phacoemulsification, persistent hypotony, and cyclodialysis clefts.

Mushtaq B, Chiang MY, Kumar V, Ramanathan US, Shah P. Mushtaq B, et al. J Cataract Refract Surg. 2005 Jul;31(7):1428-32. doi: 10.1016/j.jcrs.2004.12.049. J Cataract Refract Surg. 2005. PMID: 16105618

3

Sharps injuries in ophthalmic practice.

Ghauri AJ, Amissah-Arthur KN, Rashid A, Mushtaq B, Nessim M, Elsherbiny S. Ghauri AJ, et al. Among authors: mushtaq b. Eye (Lond). 2011 Apr;25(4):443-8. doi: 10.1038/eye.2011.13. Epub 2011 Feb 18. Eye (Lond). 2011. PMID: 21336251 Free PMC article.

4

Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom.

Alfaqawi F, Lip PL, Elsherbiny S, Chavan R, Mitra A, Mushtaq B. Alfaqawi F, et al. Among authors: mushtaq b. Eye (Lond). 2017 Apr;31(4):650-656. doi: 10.1038/eye.2016.301. Epub 2017 Jan 20. Eye (Lond). 2017. PMID: 28106887 Free PMC article.

5

Efficacy and timing of adjunctive therapy in the anti-VEGF treatment regimen for macular oedema in retinal vein occlusion: 12-month real-world result.

Lip PL, Cikatricis P, Sarmad A, Damato EM, Chavan R, Mitra A, Elsherbiny S, Yang Y, Mushtaq B. Lip PL, et al. Among authors: mushtaq b. Eye (Lond). 2018 Mar;32(3):537-545. doi: 10.1038/eye.2017.230. Epub 2017 Nov 3. Eye (Lond). 2018. PMID: 29099501 Free PMC article.

6

Proceedings from 'Clinical Audit in Retina 2017': Chairman's introduction.

Mushtaq B. Mushtaq B. Eye (Lond). 2018 Nov;32(Suppl 1):1. doi: 10.1038/s41433-018-0173-5. Eye (Lond). 2018. PMID: 30390027 Free PMC article. No abstract available.

7

A paradoxical ocular effect of brimonidine.

Mushtaq B, Sardar J, Matthews TD. Mushtaq B, et al. Am J Ophthalmol. 2003 Jan;135(1):102-3. doi: 10.1016/s0002-9394(02)01922-0. Am J Ophthalmol. 2003. PMID: 12504711

8

One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK.

Lip PL, Malick H, Damer K, Elsherbiny S, Darrad KM, Mushtaq B, Mitra A, Stavrou P, Yang Y. Lip PL, et al. Among authors: mushtaq b. Clin Ophthalmol. 2015 Sep 25;9:1779-84. doi: 10.2147/OPTH.S89147. eCollection 2015. Clin Ophthalmol. 2015. PMID: 26445525 Free PMC article.

9

Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8).

Horner F, Lip PL, Clark H, Chavan R, Sarmad A, Mushtaq B. Horner F, et al. Among authors: mushtaq b. Clin Ophthalmol. 2019 Dec 12;13:2461-2467. doi: 10.2147/OPTH.S218378. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31849444 Free PMC article.

10

Ocular syphilis unmasked following intravitreal triamcinolone injection.

Mushtaq B, Gupta R, Elsherbiny S, Murray PI. Mushtaq B, et al. Ocul Immunol Inflamm. 2009 May-Jun;17(3):213-5. doi: 10.1080/09273940902745411. Ocul Immunol Inflamm. 2009. PMID: 19585366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results